By Sarah Karlin-Smith | POLITICAL
House Republicans failed Tuesday evening to pass a “right-to-try” bill that would give terminally ill patients access to experimental drugs without FDA authorization after failing to muster enough votes to approve it through an expedited process.
The 259-140 vote fell short of the necessary two-thirds support from the House chamber. The failed vote is a setback for President Donald Trump, who called on Congress to approve the bill in his State of the Union address six weeks ago, and a small libertarian think tank that has been the driving force behind the effort.
